Cetrorelix is a man-made type of a protein that obstructs the impacts of specific hormones in the body that control ovulation (arrival of an egg from the ovary). On the off chance that ovulation happens too early amid ripeness treatment, the eggs may not be appropriate for preparation. Cetrorelix works by keeping eggs from being discharged too soon (untimely ovulation).
Cetrorelix is utilized to anticipate untimely ovulation amid controlled ovarian incitement.
Submit your review
Get emergency medical help if you have signs of an allergic reaction: hives or rash; cough, difficult breathing; feeling light-headed; swelling of your face, lips, tongue, or throat.
Some women using this medicine develop a condition called ovarian hyperstimulation syndrome (OHSS), especially after the first treatment. OHSS can be a life threatening condition.
Call your doctor right away if you have any of the following symptoms of OHSS:
stomach pain, bloating;
nausea, vomiting, diarrhea;
rapid weight gain, especially in your face and midsection;
little or no urination; or
pain when you breathe, rapid heart rate, feeling short of breath (especially when lying down).
Common side effects may include:
redness, bruising, itching, or swelling where the medicine was injected.
Ovarian stimulation therapy with gonadotropins (FSH, hMG) is started on cycle Day 2 or 3. The dose of gonadotropins should be adjusted according to individual response. Cetrotide® (cetrorelix acetate for injection) 0.25 mg may be administered subcutaneously once daily during the early- to mid-follicular phase. Cetrotide® 0.25 mg is administered on either stimulation day 5 (morning or evening) or day 6 (morning) and continued daily until the day of hCG administration.